Abstract
AbstractAlzheimer’s disease (AD) is a progressive neurodegenerative disorder whose aetiology is currently unknown. Although numerous studies have attempted to identify the genetic risk factor(s) of AD, the interpretability and/or the prediction accuracies achieved by these studies remained unsatisfactory, reducing their clinical significance. Here, we employ the ensemble of random-forest and regularized regression model (LASSO) to the AD-associated microarray datasets from four brain regions - Prefrontal cortex, Middle temporal gyrus, Hippocampus, and Entorhinal cortex- to discover novel genetic biomarkers through a machine learning-based feature-selection classification scheme. The proposed scheme unrevealed the most optimum and biologically significant classifiers within each brain region, which achieved by far the highest prediction accuracy of AD in 5-fold cross-validation (99% average). Interestingly, along with the novel and prominent biomarkers including CORO1C, SLC25A46, RAE1, ANKIB1, CRLF3, PDYN, numerous non-coding RNA genes were also observed as discriminator, of which AK057435 and BC037880 are uncharacterized long non-coding RNA genes.
Publisher
Cold Spring Harbor Laboratory
Reference103 articles.
1. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;The Lancet Neurology,2019
2. Wimo, A. & Prince, M. World Alzheimer Report 2015, The Global Impact of Dementia. Alzheimer’s Dis. Int. (2015).
3. Prince, M. , Comas-Herrera, A. , Knapp, M. , Guerchet, M. & Karagiannidou, M. World Alzheimer Report 2016. Improving healthcare for people living with dementia. Alzheimer’s Dis. Int. (2016).
4. Alzheimer Mechanisms and Therapeutic Strategies
5. Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults